Combining Lipo C with Mounjaro Metabolism Support Stack Combining Lipo C with Mounjaro Metabolism Support Stack A 2024 retrospective analysis from Johns Hopkins found that patients combining lipotropic injections with GLP-1 receptor agonist therapy experienced 23% greater reduction in hepatic steatosis compared to GLP-1 monotherapy at 16 weeks
However, compounded semaglutide is not FDA-approved like the brand name drugs
USA Today noted that while employers often cover the cost of diabetes medications such as Ozempic and Lillys Mounjaro for their workers, employers are less likely to pick up the tab for weight-loss medications. KFF, quoted in the USA Today article, said 43% of larger employers paid for anti-obesity drugs last year
Liu RT, Chung MS, Wang PW, et al
J Diet Suppl 16:431442 Balmus IM, Ciobica A, Trifan A, Stanciu C (2016) The implications of oxidative stress and antioxidant therapies in Inflammatory Bowel Disease: Clinical aspects and animal models
They can help decide if either option is best for your needs
